title: Association of a brain methylation site with clinical outcomes in depression does not replicate across populations.
authors.affiliation: From the Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada; King's College London, Institute of Psychiatry, Psychology & Neuroscience, MRC Social, Genetic and Developmental Psychiatry Centre, London; Broad Institute, Cambridge, Mass.; Massachusetts General Hospital, Boston; Institute of Translational Medicine, University of Liverpool, United Kingdom; Max Planck Institute of Psychiatry, Munich, Germany; and Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
authors.forename: Rudolf
authors.initials: R
authors.lastname: Uher
authors.forename: Stephan
authors.initials: S
authors.lastname: Ripke
authors.forename: Bertram
authors.initials: B
authors.lastname: Müller-Myhsok
authors.forename: Cathryn M
authors.initials: CM
authors.lastname: Lewis
authors.forename: Roy H
authors.initials: RH
authors.lastname: Perlis
mesh_terms: D000928:Antidepressive Agents / Q000627:therapeutic use*; D019208:Brain-Derived Neurotrophic Factor / Q000235:genetics*; D003865:Major Depressive Disorder / Q000188:drug therapy*; D003891:Desipramine / Q000627:therapeutic use*; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D017058:Mexican Americans; D020641:Polymorphism, Single Nucleotide
chemical_list: D000928:Antidepressive Agents; D019208:Brain-Derived Neurotrophic Factor; D005473:Fluoxetine; D003891:Desipramine